Virtual apertures let researchers isolate and solve atomic structures from individual nanocrystals embedded in dense clusters, providing valuable new data for energy and pharmaceutical applications.
David G. Hunter is president of the American Association for Pediatric Ophthalmology and Strabismus, a professor of ophthalmology at Harvard Medical School and co-founder of the medical device company ...
Astronomers have produced the most detailed map yet of dark matter, revealing the invisible framework that shaped the Universe long before stars and galaxies formed. Using powerful new observations ...
Changes in corneal topography can be due to factors other than use of high or low concentration atropine, e.g., myopic axial lengthening and globe growth. Corneal shape — and ocular astigmatism — may ...
The Nike Structure Plus is built to be the softest, springiest stability shoe Nike has ever made, and uses the brand’s ZoomX foam for the first time in a stability shoe. It does achieve its goals in ...
Chemists have constructed the complex natural products secalosides A and B from simple chemical building blocks for the first time. The total synthesis has been key to identifying the molecules’ ...
Anchor your business to a stubborn, real-world problem customers cannot ignore. Replace hustle with systems that standardize decisions, data flow and accountability. Ambition isn’t what holds ...
Submitted data were not enough to support the effectiveness of SYD-101 in children with myopia, according to the FDA. The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) ...
Sydnexis Receives Complete Response Letter from FDA for SYD-101 to Slow Pediatric Myopia Progression
DEL MAR, Calif.--(BUSINESS WIRE)--Sydnexis, Inc., (www.sydnexis.com), a biopharmaceutical company focused on pediatric progressive myopia (PPM), today announced that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results